百菌清制剂
Search documents
苏利股份:公司是全球第二大的百菌清原药生产企业,在江苏和宁夏地区均有产线布局
Zheng Quan Ri Bao Wang· 2025-12-19 11:43
Core Viewpoint - The company, Sully Co., is the second-largest producer of the fungicide technical material, Bacillus subtilis, globally, with production lines in Jiangsu and Ningxia, operating at full capacity and achieving industry-leading efficiency [1] Group 1: Production and Capacity - The company has a single-line production capacity of 10,000 tons in Ningxia, which is the largest in China [1] - Both production sites are currently operating at full capacity, indicating strong operational efficiency [1] Group 2: Market Demand and Pricing - There is a stable global demand for Bacillus subtilis, particularly in South America, where usage is significantly high [1] - The price of Bacillus subtilis is on the rise, reflecting the increasing demand [1] Group 3: Sales and Supply Chain - The company supplies Bacillus subtilis to major international manufacturers and is also directly selling formulated products, with rapid growth in sales scale [1] - The company is actively researching to provide high-quality Bacillus subtilis products in response to observed supply chain risks in the market [1] - The company is engaged in negotiations with customers regarding product pricing to enhance shareholder value [1]